Who We Are | ImmunoGen for Cancer Treatment using ADC Technology
IMMUNOGEN IS NOW PART OF ABBVIE Together we will be working to make a remarkable impact for cancer patients and their communities of care, raising standards of care and advancing a dynamic oncology pipeline. For 40 years, ImmunoGen has been researching and developing ADCs designed to disrupt the progression of cancer. Because we believe life deserves fewer interruptions and more good days.
This company is:
Verified
ImmunoGen Announces Proposed Public Offering of Common Stock - ImmunoGen
ImmunoGen Announces Proposed Public Offering of Common Stock
Verified
ImmunoGen Announces Proposed Public Offering of Common Stock - ImmunoGen
ImmunoGen Announces Proposed Public Offering of Common Stock
Verified
ImmunoGen Announces Pricing of Public Offering of Common Stock - ImmunoGen
ImmunoGen Announces Pricing of Public Offering of Common Stock
View all products
Keywords
Industries
ImmunoGen Submits Biologics License Application to the US Food and Drug Administration for Mirvetuximab Soravtansine in Ovarian Cancer - ImmunoGen
ImmunoGen Submits Biologics License Application to the US Food and Drug Administration for Mirvetuximab Soravtansine in Ovarian Cancer
Where is ImmunoGen located?
The company ImmunoGen is located in Waltham, Massachusetts, United States. It's worth noting that the company may has more corporate locations
How many employees does ImmunoGen approximately have?
As of the latest available information ImmunoGen has around 501-1000 employees worldwide.
When was ImmunoGen founded?
ImmunoGen was founded in 1981
In which industries does ImmunoGen mainly work?
The company ImmunoGen has it's main focus in the industries of Science and Engineering, Others, Health Care, Manufacturing, Biotechnology
What is the current company status of ImmunoGen?
Based on the founding year and the amount of employees the company ImmunoGen seems to be a Medium-Sized Company at the current state. Note that over time that status can change
ImmunoGenesis
United States
11-50 Employees
2019
Agenus
United States
251-500 Employees
1994
Immunitas Therapeutics
United States
11-50 Employees
2019
NantKwest
United States
51-100 Employees
2002
Ambrx
United States
101-250 Employees
2003
Exinda Therapeutics, LLC
United States
1-10 Employees
2013
Inimmune
United States
11-50 Employees
2016
ImaginAb
United States
11-50 Employees
2007
Topics which have been searched by others and may be interesting for you: